OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2023
(4)
2025
(2)
2024
(2)
2022
(2)
2021
(2)
2019
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma.
Not available
S-EPMC4731307
|
biostudies-literature
Cite
Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry.
Not available
S-EPMC6865235
|
biostudies-literature
Cite
Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical Trial.
Not available
S-EPMC11791705
|
biostudies-literature
Cite
Cortisol awakening response and developmental outcomes at 6-7 years in children born extremely preterm.
Not available
S-EPMC9758271
|
biostudies-literature
Cite
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Not available
S-EPMC11252333
|
biostudies-literature
Cite
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
Not available
S-EPMC10751594
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets